EUVIMEDScopri EUVIMED
Systematische Übersicht

Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review

Sara Rahavi-Ezabadi iD, Sheng Zhou, Stella E Lee, Elisabeth Ference, Anthony Magit, Shelby Leuin, Kawthar Mohamed, Nima Rezaei, Vijay A Patel iD

Otolaryngology–Head and Neck Surgery · 2024

DOI: 10.1002/ohn.717 ↗

At a glance

Systematische Übersicht in Otolaryngology–Head and Neck Surgery, 2024. Written by Sara Rahavi-Ezabadi and 8 co-authors. Institution: Department of Otorhinolaryngology-Head and Neck Surgery, Otorhinolaryngology Research Center, Children's Medical Center, Tehran University of Medical…. Major MEDLINE topics: Sinusitis, Rhinitis, Biological Therapy. Cited 8 times so far (Crossref); 63 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

Provide clinicians with current evidence for biologic therapy in children with chronic rhinosinusitis with nasal polyposis (CRSwNP). Data Sources PubMed, MEDLINE, Cochrane, and clinical trial registries. Review Methods Key search terms related to biologic therapy in pediatric CRSwNP were identified via a structured query of current medical literature and clinical trial databases.

Conclusions

There is a dearth of active clinical trials and research studies for biologics targeting pediatric CRSwNP. There is an ongoing compassionate‐use clinical trial involving Dupilumab for children with nasal polyps as well as only 1 published work specifically focused on Dupilumab for pediatric CRSwNP in the setting of aspirin‐exacerbated respiratory disease.

Implications for Practice

For children with atopic dermatitis, asthma, and chronic idiopathic urticaria, biologic therapies such as Omalizumab, Dupilumab, and Mepolizumab have gained Food and Drug Administration approval. The role of biologic therapy in pediatric CRSwNP demonstrates significant promise in the comprehensive management of the unified airway. Additional Phase III trials are necessary to broaden clinical indications for children with comorbid conditions and complex sinonasal disease.

Subjects

MeSH terms (MEDLINE)

SinusitisRhinitisBiological TherapyHumansChronic DiseaseChildNasal PolypsOmalizumabRhinosinusitisAntibodies, Monoclonal, Humanized

Author keywords

biologics childrenchronic rhinosinusitismAbnasal polypspediatricrhinosinusitis

Substances

dupilumabOmalizumabAntibodies, Monoclonal, Humanized

Authors and institutions

  • Department of Otorhinolaryngology-Head and Neck Surgery, Otorhinolaryngology Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • USC Caruso Department of Otolaryngology-Head and Neck Surgery, Los Angeles, California, USA.
  • Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Otolaryngology, Facey Medical Group, Los Angeles, California, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of California San Diego, La Jolla, California, USA.
  • Division of Pediatric Otolaryngology, Rady Children's Hospital-San Diego, San Diego, California, USA.

ORCID profiles: Sara Rahavi-Ezabadi, Vijay A Patel

Cite

APA

Rahavi-Ezabadi, S., Zhou, S., Lee, S. E., Ference, E., Magit, A., Leuin, S., Mohamed, K., Rezaei, N., & Patel, V. A. (2024). Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.717

Vancouver

Rahavi-Ezabadi S, Zhou S, Lee SE, Ference E, Magit A, Leuin S, et al. Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.717

BibTeX
@article{RahaviEzabadi2024,
  author = {Rahavi-Ezabadi, Sara and Zhou, Sheng and Lee, Stella E and Ference, Elisabeth and Magit, Anthony and Leuin, Shelby and Mohamed, Kawthar and Rezaei, Nima and Patel, Vijay A},
  title = {Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  doi = {10.1002/ohn.717}
}
Start for free →